Nuwellis, Inc. It was a year of structural change and deliberate repositioning. While full-year revenue declined 5% compared to 2024, the defining characteristic of 2025 was not top-line variability.
Thank you, and good afternoon, everyone, and welcome to Finance Of America Companies Inc.'s fourth quarter and full year 2025 earnings call. With me today are Graham A. Fleming, Chief Executive ...
Hello, and welcome, everyone, joining today's Nuwellis Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this call is being recorded. [Operator Instructions] It is now ...
Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDTCompany ParticipantsMark Kaye - Executive VP ...
Earnings call UEC reported over $20 million in revenue and $10 million in gross profit from uranium sales at $101/lb—25% above the market average—while ending the quarter with $818 million in ...
Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...
The new industry-leading bilingual model includes the world's first Arabic--English bilingual medical model, achieving 6.3% WER on mixed-speech benchmarks and 35% fewer errors than the nearest ...
Verizon Business talked at MWC about how its sees the new AI stack evolving for telcos, and why its investments in backbone fiber, metro access, and private network will link cloud models and ...
Jason Witten walked to the interview table with a smile from ear to ear. He went around the pile of reporters, shaking each hand while introducing himself to everyone. It’s not often a coach does this ...
Even as Gateway tunnel construction resumes after a court-ordered release of federal funds, officials warn the $16B Northeast Corridor megaproject could face another shutdown within months if ...
Sandoz (SDZNY) announced on Tuesday the creation of a new biosimilar unit in a bid to target off-patent versions of biologics worth over $650B that are expected to lose market exclusivity over the ...
Citing a congressional investigation, The Wall Street Journal reported on Tuesday that due to alleged overpayments to Medicare Advantage health plans, Medicare Part B premiums increased by $13.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results